# AN2 Therapeutics, Inc.: Form DEF 14A, filed Apr 10, 2025

- Company: [AN2 Therapeutics, Inc.](/companies/antx.md) (CIK 1880438)
- Form: DEF 14A
- Filed: 2025-04-10
- Accepted by EDGAR: Apr 10, 2025, 20:05 ET
- Period: 2025-04-10
- Accession: 0000950170-25-052852
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1880438/000095017025052852/antx-20250410.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1880438/000095017025052852/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1880438/000095017025052852/antx-20250410.htm

Filed Apr 10, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-052852. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.